Search research articles
Contact Us
Filters
Showing results (431-440 of 621) with videos related to
Page
of 63
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 26, 2020
Association of Anti-Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti-Topoisomerase I-Positive Systemic Sclerosis
Maaike Boonstra, Jaap A Bakker, Annette Grummels, et al.
The Lancet. Rheumatology
|
January 24, 2024
Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts
Sophie I E Liem, Maaike Boonstra, Saskia le Cessie, et al.
Current Respiratory Medicine Reviews
|
March 29, 2016
Outcome Measures for Clinical Trials in Interstitial Lung Diseases
Matthew R Lammi, Robert P Baughman, Surinder S Birring, et al.
RMD Open
|
March 5, 2026
Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of ≤1 year of back pain: longitudinal observational data from the SCQM registry
Mauro Bachmann, Andrea Götschi, Annik Steimer, et al.
Annals of the Rheumatic Diseases
|
August 2, 2015
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database
Elina G Wirz, Veronika K Jaeger, Yannick Allanore, et al.
Annals of the Rheumatic Diseases
|
April 27, 2016
Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis
Katrin Palumbo-Zerr, Alina Soare, Pawel Zerr, et al.
RMD Open
|
February 28, 2025
Validation of a semi-quantitative method to assess interstitial lung disease severity and progression in systemic sclerosis by standard and low-dose HRCT scans
Lucas Tschalèr, Suzana Jordan, Trond Mogens Aaløkken, et al.
Annals of the Rheumatic Diseases
|
March 13, 2014
Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
Christian Beyer, Jingang Huang, Jürgen Beer, et al.
Annals of the Rheumatic Diseases
|
June 27, 2025
Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis
Ludwig Ueberall, Hashem Mohammadian, Richard Demmler, et al.
JCI Insight
|
April 22, 2026
FOSL2 regulates endothelial cell state and chromatin accessibility in systemic sclerosis pulmonary vascular remodeling
Rithika Behera, Yuechen Zhou, Peter H Gerges, et al.
Page
of 63
Search research articles
Search
Showing results (431-440 of 621) with videos related to
Sort By:
Page
of 63
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 26, 2020
Association of Anti-Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti-Topoisomerase I-Positive Systemic Sclerosis
Maaike Boonstra, Jaap A Bakker, Annette Grummels, et al.
The Lancet. Rheumatology
|
January 24, 2024
Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts
Sophie I E Liem, Maaike Boonstra, Saskia le Cessie, et al.
Current Respiratory Medicine Reviews
|
March 29, 2016
Outcome Measures for Clinical Trials in Interstitial Lung Diseases
Matthew R Lammi, Robert P Baughman, Surinder S Birring, et al.
RMD Open
|
March 5, 2026
Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of ≤1 year of back pain: longitudinal observational data from the SCQM registry
Mauro Bachmann, Andrea Götschi, Annik Steimer, et al.
Annals of the Rheumatic Diseases
|
August 2, 2015
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database
Elina G Wirz, Veronika K Jaeger, Yannick Allanore, et al.
Annals of the Rheumatic Diseases
|
April 27, 2016
Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis
Katrin Palumbo-Zerr, Alina Soare, Pawel Zerr, et al.
RMD Open
|
February 28, 2025
Validation of a semi-quantitative method to assess interstitial lung disease severity and progression in systemic sclerosis by standard and low-dose HRCT scans
Lucas Tschalèr, Suzana Jordan, Trond Mogens Aaløkken, et al.
Annals of the Rheumatic Diseases
|
March 13, 2014
Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
Christian Beyer, Jingang Huang, Jürgen Beer, et al.
Annals of the Rheumatic Diseases
|
June 27, 2025
Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis
Ludwig Ueberall, Hashem Mohammadian, Richard Demmler, et al.
JCI Insight
|
April 22, 2026
FOSL2 regulates endothelial cell state and chromatin accessibility in systemic sclerosis pulmonary vascular remodeling
Rithika Behera, Yuechen Zhou, Peter H Gerges, et al.
Page
of 63